These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30455147)
1. Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments. Chowdhury SR; Kennedy S; Zhu K; Mishra R; Chuong P; Nguyen AU; Kathman SG; Statsyuk AV Bioorg Med Chem Lett; 2019 Jan; 29(1):36-39. PubMed ID: 30455147 [TBL] [Abstract][Full Text] [Related]
2. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors? Torkar A; Lenarčič B; Lah T; Dive V; Devel L Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells. Li Y; Ai X; Zou C; Liu Y; Ma L; Men J; Liu D; Sheng L; Ruan X; Liu H; Li W; Ma E; Yuan L Bioorg Chem; 2021 Oct; 115():105256. PubMed ID: 34426153 [TBL] [Abstract][Full Text] [Related]
4. In silico identification of irreversible cathepsin B inhibitors as anti- cancer agents: virtual screening, covalent docking analysis and molecular dynamics simulations. Sbongile M; Soliman ME Comb Chem High Throughput Screen; 2015; 18(4):399-410. PubMed ID: 25747438 [TBL] [Abstract][Full Text] [Related]
5. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain. McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866 [TBL] [Abstract][Full Text] [Related]
6. New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8. Fey P; Chartomatsidou R; Kiefer W; Mottram JC; Kersten C; Schirmeister T Eur J Med Chem; 2018 Aug; 156():587-597. PubMed ID: 30029081 [TBL] [Abstract][Full Text] [Related]
7. Triterpenoids as novel natural inhibitors of human cathepsin L. Ramalho SD; De Sousa LR; Nebo L; Maganhi SH; Caracelli I; Zukerman-Schpector J; Lima MI; Alves MF; Da Silva MF; Fernandes JB; Vieira PC Chem Biodivers; 2014 Sep; 11(9):1354-63. PubMed ID: 25238076 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype. Myers MC; Shah PP; Beavers MP; Napper AD; Diamond SL; Smith AB; Huryn DM Bioorg Med Chem Lett; 2008 Jun; 18(12):3646-51. PubMed ID: 18499453 [TBL] [Abstract][Full Text] [Related]
14. Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Boudreau PD; Miller BW; McCall LI; Almaliti J; Reher R; Hirata K; Le T; Siqueira-Neto JL; Hook V; Gerwick WH J Med Chem; 2019 Oct; 62(20):9026-9044. PubMed ID: 31539239 [TBL] [Abstract][Full Text] [Related]
15. Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L. Ashhurst AS; Tang AH; Fajtová P; Yoon MC; Aggarwal A; Bedding MJ; Stoye A; Beretta L; Pwee D; Drelich A; Skinner D; Li L; Meek TD; McKerrow JH; Hook V; Tseng CT; Larance M; Turville S; Gerwick WH; O'Donoghue AJ; Payne RJ J Med Chem; 2022 Feb; 65(4):2956-2970. PubMed ID: 34730959 [TBL] [Abstract][Full Text] [Related]
16. Advances in the discovery of cathepsin K inhibitors on bone resorption. Lu J; Wang M; Wang Z; Fu Z; Lu A; Zhang G J Enzyme Inhib Med Chem; 2018 Dec; 33(1):890-904. PubMed ID: 29723068 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K. Wang Y; Xue S; Li R; Zheng Z; Yi H; Li Z Bioorg Med Chem; 2018 Jan; 26(1):8-16. PubMed ID: 29223717 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L. Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052 [TBL] [Abstract][Full Text] [Related]
19. Asymmetric synthesis and evaluation of epoxy-α-acyloxycarboxamides as selective inhibitors of cathepsin L. Dos Santos DA; Deobald AM; Cornelio VE; Ávila RMD; Cornea RC; Bernasconi GCR; Paixão MW; Vieira PC; Corrêa AG Bioorg Med Chem; 2017 Sep; 25(17):4620-4627. PubMed ID: 28720327 [TBL] [Abstract][Full Text] [Related]
20. Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds. Zhang L; Howland M; Hilgenfeld R; Anderson MO; Eagon S Bioorg Med Chem Lett; 2021 Jun; 41():127990. PubMed ID: 33775840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]